Valneva’s integrated business model is based on valuable commercial and R&D assets in important, high-value niches.
Q1 Results 2020
Valneva Reports Q1 Results and Updates 2020 Guidance Following Major Lyme Partnering Deal.
View MoreUpcoming Events
June 2, 2020
Jefferies Virtual Healthcare Conference
June 8, 2020
BIO Digital
Contact
Investor Relations Team
Campus Bio-Ouest6, Rue Alain Bombard
44800 Saint-Herblain, France T: +33 2 28 07 37 10 investors@valneva.com